期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Persistent efficacy of live attenuated hepatitis A vaccine (H2-strain) after a mass vaccination program 被引量:6
1
作者 ZHUANG Fang-cheng QIAN Wen +6 位作者 MAO Zi-an GONG Yue-ping JIANG Qi JIANG Li-min CHEN Nian-liang CHAI Shao-ai MAO Jiang-sen 《Chinese Medical Journal》 SCIE CAS CSCD 2005年第22期1851-1856,共6页
Background Live attenuated hepatitis A vaccine ( H2 strain) is widely applied in prevention of hepatitis A epidemic in China and other countries now. It is essential to observe and confirm the vaccine immune efficac... Background Live attenuated hepatitis A vaccine ( H2 strain) is widely applied in prevention of hepatitis A epidemic in China and other countries now. It is essential to observe and confirm the vaccine immune efficacy, population antibody level and its persistent efficacy after mass immunization. Methods A total of 220 children with negative anti-HAV antibody ( aged 1-3 years) were taken for follow-up assay to observe seroconversion and geometric mean titre(GMT) level 2 months, 12 months, 6 years, and 10 years after inoculation. Another survey sampled from subjects of different age groups (3, 6, 9, 15, 18, 25 and 35 years) to compare anti-HA antibody positive rate before and after inoculation performed 10 years previously. Epidemiological observations were taken for 10 years to evaluate the relationship between vaccine coverage and hepatitis A morbidity. Serum antibody to HAV was detected by enzyme linked immunoassay (ELISA, calibrated by WHO international reference) and ABBOTY Axsym HAVAB microparticle enzyme immunoassay. Results Seroconversion in follow-up assay 2 months and 10 years after inoculation was 98.6% and 80. 2% respectively. For children, the vaccination anti-HA antibody positive rates were significantly different before and after 10 years, 7.69% cf 70.45% (aged 3 years) and 52. 58% cf 71.78% (aged 18 years). When vaccine coverage rose from 57% to 74%, there were no any HA epidemics. When vaccine coverage reached 85%, there were no any HA cases. With vaccine coverage between 85% and 91%, there were no any HA cases in cohorts from the age of 1 year to 15 years during the 10 years. Conclusions Live attenuated hepatitis A vaccine has an obvious long-term effectiveness in prevention and control of HA epidemics through mass vaccination. 展开更多
关键词 hepatitis A vaccines persistent efficacy mass vaccination
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部